Sharon Cantor
Affiliations: | University Of Massachusetts Med Sch Worcester |
Google:
"Sharon Cantor"Mean distance: (not calculated yet)
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zaino AM, Dash RC, James SJ, et al. (2024) Lead compound profiling for small molecule inhibitors of the REV1-CT/RIR Translesion synthesis Protein-Protein interaction. Bioorganic & Medicinal Chemistry. 106: 117755 |
| Cong K, MacGilvary N, Lee S, et al. (2024) FANCJ promotes PARP1 activity during DNA replication that is essential in BRCA1 deficient cells. Nature Communications. 15: 2599 |
| Cong K, MacGilvary N, Lee S, et al. (2024) FANCJ promotes PARP1 activity during DNA replication that is essential in BRCA1 deficient cells. Biorxiv : the Preprint Server For Biology |
| Whalen JM, Cantor SB. (2023) Unveiling the toxicity of single-stranded DNA gaps through a yeast model. Nature Structural & Molecular Biology. 30: 870-872 |
| Cong K, Cantor SB. (2022) Exploiting replication gaps for cancer therapy. Molecular Cell |
| Cantor SB. (2021) Revisiting the BRCA-pathway through the lens of replication gap suppression: "Gaps determine therapy response in BRCA mutant cancer". Dna Repair. 107: 103209 |
| Cong K, Peng M, Kousholt AN, et al. (2021) Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency. Molecular Cell |
| Lee WTC, Yin Y, Morten MJ, et al. (2021) Single-molecule imaging reveals replication fork coupled formation of G-quadruplex structures hinders local replication stress signaling. Nature Communications. 12: 2525 |
| Nayak S, Calvo JA, Cantor SB. (2021) Targeting translesion synthesis (TLS) to expose replication gaps, a unique cancer vulnerability. Expert Opinion On Therapeutic Targets. 25: 27-36 |
| Panzarino NJ, Krais JJ, Cong K, et al. (2020) Replication Gaps Underlie BRCA-deficiency and Therapy Response. Cancer Research |